Mikako Fujita

23PUBLICATIONS
87CO-AUTHORS
Biologically active moleculesMolecular targetsReaction engineering (excl. nuclear reactions)Gene and molecular therapyCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Mar 28, 2026
Harnessing Substituted 4-Chlorothieno[2,3-b]pyridine as a New Cap for Potent and Selective Antiproliferative HDAC Inhibitors.

Mostafa M Badran, Berkay Beyri, Hiroshi Tateishi

|Jan 28, 2026
Hydrazonylthiazole Derivatives as Dual EGFR and ALR2 Inhibitors: Design, Synthesis, and Comprehensive In Vitro and In Silico Evaluation for Potential Anticancer Activity.

Belgin Sever, Cüneyt Türkeş, Yeliz Demir

|Aug 14, 2025
Design, Synthesis, and Anticancer Evaluation of New Small-Molecule EGFR Inhibitors Targeting NSCLC and Breast Cancer.

Belgin Sever, Masami Otsuka, Mikako Fujita

|Jul 18, 2025
Insights into therapeutic discovery through the Kelch domain structure of Keap1 at ambient temperature.

Merve Yilmaz, Belgin Sever, Yiğit Kutlu

|Feb 26, 2025
Design, Synthesis, and Mechanistic Anticancer Evaluation of New Pyrimidine-Tethered Compounds.

Farida Reymova, Belgin Sever, Edanur Topalan

|Jan 09, 2025
New naphthalene-linked pyrazoline-thiazole hybrids as prominent antilung and antibreast cancer inhibitors.

Halilibrahim Çiftçi, Masami Otsuka, Mikako Fujita

Pageof 4

Frequent Collaborators

16 joint publications

Halilibrahim Ciftci

13 joint publications

Belgin Sever

11 joint publications

Hiroshi Tateishi

9 joint publications

Mohamed Osman Radwan